Vitamin B12 fluorescent-analogues - Vestan

Drug Profile

Vitamin B12 fluorescent-analogues - Vestan

Alternative Names: CobalaFluor Green; CobalaFluor Red; Fluorescent cobalamin analogues - Vestan

Latest Information Update: 26 Jun 2014

Price : $50

At a glance

  • Originator University of Utah
  • Developer Vestan
  • Class Diagnostic agents; Diagnostic conjugates; Vitamin B12 analogues
  • Mechanism of Action Diagnostic imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Breast cancer

Most Recent Events

  • 31 Dec 2006 Launched for Breast cancer (diagnosis) in USA (IV)
  • 31 Dec 2006 Launched for Breast cancer (diagnosis) in USA (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top